Diovan and Butrans drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diovan (valsartan) and Butrans (buprenorphine). Common drug interactions include application site burn among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Diovan and Butrans. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.

What is Butrans?

Butrans has active ingredients of buprenorphine. It is often used in pain. eHealthMe is studying from 64,148 Butrans users. Check the latest studies of Butrans.



On Aug, 11, 2026

30 people who take Diovan and Butrans together, and have interactions are studied.

Diovan and Butrans drug interactions.

What are the common drug interactions of Diovan and Butrans, by gender? *:

female:

  1. Application site burn
  2. Application site vesicles (small bubble within a cell at application site)
  3. Chronic kidney disease
  4. Pain in extremity
  5. Nausea (feeling of having an urge to vomit)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Alopecia (absence of hair from areas of the body)
  8. Fall
  9. Renal failure (kidney dysfunction)
  10. Application site exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface)

male:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Confusional state
  4. Crying
  5. Drug dependence
  6. Drug diversion
  7. Fall
  8. Hallucination (an experience involving the perception of something not present)
  9. Intervertebral disc protrusion (spinal disc protrusion)
  10. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

What are the common drug interactions of Diovan and Butrans, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Cardiac disorder
  3. Crying
  4. Drug dependence
  5. Drug diversion
  6. Heart rate increased
  7. Infusion related reaction
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Osteomyelitis (infection of bone)
  10. Oxygen saturation decreased

50-59:

  1. Chronic kidney disease
  2. Alopecia (absence of hair from areas of the body)
  3. Hot flush (sudden feelings of heat)
  4. Priapism (prolonged and painful erection that can last from several hours up to a few days)
  5. Renal failure (kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Stress
  8. Vision blurred

60+:

  1. Anaemia (lack of blood)
  2. Epistaxis (bleed from the nose)
  3. Blood pressure fluctuation
  4. Drug ineffective
  5. Aphasia (damage to the parts of the brain that control language)
  6. Back pain
  7. Cardiac failure congestive
  8. Cellulitis (infection under the skin)
  9. Confusional state
  10. Device related infection

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 13.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 13.33%
  4. Gout (uric acid crystals building up in the body): 3 people, 10.00%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.00%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 10.00%
  7. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.67%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
  9. Osteoporosis (bones weak and more likely to break): 2 people, 6.67%
  10. Neuropathy Peripheral (surface nerve damage): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Diovan and Butrans?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diovan and Butrans:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Butrans:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diovan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Butrans and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on valsartan and buprenorphine (the active ingredients of Diovan and Butrans, respectively), and Diovan and Butrans (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: